相关实验视频
Updated: May 23, 2025

08:02
A Mouse Ear Model for Allergic Contact Dermatitis Evaluation
Published on: March 24, 2023
3.1K
PeiTuQingXin配方通过抑制TRADD/TRAF2/RIP1复杂介导NF-κB信号通路激活来缓解亚托皮性皮炎症状
Zixuan Cheng1, Xin Ma1, Feng Luo1
1The Second Clinical School of Medicine, Guangzhou University of Traditional Chinese Medicine, Guangzhou, China.
Archives of dermatological research
|March 8, 2025
概括
PTQX配方通过降低炎症和IgE水平,有效治疗皮炎 (AD). 它通过抑制TRADD/TRAF2/RIP1复合体和下调NF-κB信号通路而起作用.
科学领域:
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
- 传统中国医药 传统中国医药
背景情况:
- 亚托皮炎 (AD) 是一种慢性炎症性皮肤疾病.
- 传统中国医学 (TCM) 为AD提供了潜在的治疗策略.
- 暴露于室内灰尘虫 (HDM) 是AD恶化的一个常见触发因素.
研究的目的:
- 评估PTQX配方在HDM诱导的AD小鼠模型中的疗效.
- 阐明PTQX配方在AD中的抗炎作用的潜在分子机制.
主要方法:
- 建立了一个HDM诱导的AD小鼠模型 (NC/Nga小鼠),并用PTQX配方进行治疗.
- 测量了血清IgE水平,炎症性细胞因子和Th2细胞比率.
- 基因和基因组的京都百科全书 (KEGG) 途径分析和数据独立获取 (DIA) 蛋白质组学被采用.
- 西方涂抹被用来分析蛋白质表达和信号通路活动.
主要成果:
- PTQX配方显著缓解了皮肤炎,将血清IgE降低了2倍以上,并降低了炎症性细胞因子水平.
- 治疗降低了Th2细胞比率,并调节了NF-κB和Toll类受体信号通路.
- 蛋白质组学发现了149种受调节的蛋白质,TRADD的显著下调.
- 西部涂抹证实TRADD,TRAF2和RIP1的表达减少,抑制NF-κB通路活性.
结论:
- PTQX配方在HDM诱导的AD模型中显示出显著的抗炎和抗皮炎作用.
- 治疗机制包括抑制TRADD/TRAF2/RIP1复合体和抑制NF-κB信号传递.
- PTQX配方代表了一种有前途的基于TCM的治疗阿托皮性皮肤炎.
相关概念视频
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K

